Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Arthritis × Infliximab × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Arthritis, Rheumatoid 6 Melanoma 5 Inflammatory Bowel Diseases 4 Crohn Disease 4 Colitis, Ulcerative 4 Carcinoma, Non-Small-Cell Lung 4 Lung Neoplasms 3 Colitis 3 Urogenital Neoplasms 2 Hematologic Neoplasms 2 Depressive Disorder, Major 2 Depression 2 Cachexia 2 Anorexia 2 Vasculitis 1 Takayasu Arteritis 1 Syndrome 1 Stroke 1 Stevens-Johnson Syndrome 1 Spondylitis, Ankylosing 1 Skin Neoplasms 1 Rare Diseases 1 Psoriasis 1 Precancerous Conditions 1 Pemphigoid, Benign Mucous Membrane 1 Pancreatic Neoplasms 1 Lymphoma 1 Kidney Transplantation 1 Inflammation 1 Infections 1

Interventions

upadacitinib 1 tocilizumab 1 methyl hydroxyethyl cellulose 1 acetaminophen, aspirin, caffeine drug combination 1 Walking 1 Radiotherapy 1 Omeprazole 1 Nutrition Assessment 1 Naproxen 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Lysine Acetyltransferase 5 1 Injections, Intra-Articular 1 Infliximab 1 Immune Checkpoint Inhibitors 1 Holistic Health 1 Febuxostat 1 Exergaming 1 Etanercept 1 Collagenases 1 Colchicine 1 Blood Specimen Collection 1 Arthroplasty, Replacement, Shoulder 1 Arthroplasty, Replacement, Elbow 1 Allopurinol 1 Adalimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05379049 2022-05-18

TNF-alpha

University of Sulaimani

Arthritis, Arthritis, Rheumatoid, Spondylitis, Ankylosing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡